Risky Business: The Pharmaceutical Industry Boardgame
A highly stimulating programme on pharmaceutical R&D and BD&L in the form of a boardgame called Risky Business.
Read more…
Decision Analysis in Pharmaceutical R&D
Courses for R&D portfolio managers and R&D project leaders and teams to improve strategic decision making.
Customised Progammes
We tailor existing courses on strategy and decision analysis or create new courses for specific training needs.
Read more…
Scheduled Courses
Scheduled decision analysis courses are open for registration. Check the Training Calendar for the next course at The Catenion Academy’s facilities in Berlin.
"Great training: just the right balance of background theory and an in−depth, hands−on case study. Catenion helped us both with their consulting team to develop a portfolio process and review, and then the Catenion Academy was instrumental to ensure implementation."
Dr. Ulrich Betz
Department Head
Strategic Innovation &
Research Portfolio Management
Merck Serono
Decision Analysis Courses
The Catenion Academy’s courses in decision analysis help pharmaceutical R&D portfolio managers and project teams significantly improve the way they assess the risk, potential and status of projects and portfolios to increase the chances for success.
Our decision analysis training offerings are of two types and cover discovery, early−stage or late−stage clinical development projects:
Decision Analysis for R&D Portfolio Managers
The focus of this course is on managing strategic portfolio options. The course modules include option space mapping; risk assessment; innovativeness screening; project synthesis; and portfolio prioritisation.
Courses & Fees for R&D Portfolio Managers
Learning Objectives
Using a real–world lead optimisation (LO) project example, participants will learn how to
- Avoid the pitfalls of "market–driven" TPPs
- Develop strategic options for possible market positioning and development strategies
- Derive inputs into the targeted LO and PC compound profiles
- Set milestones for continuing or abandoning the preferred options
- Get a firm grasp of the competitive dynamics and market situation of each option
- Understand the specific risk profile inherent in each option
- Portfolio managers will gain hands on experience in the effective use of real–life processes, methods and tools for future use
- Participants will learn how to balance the different perspectives of project teams, decision makers and portfolio managers
Modules
The selected modules for this course are:
- Option Space Mapping
- Risk Assessment
- Innovativeness Screening
- Project Synthesis
- Portfolio Prioritisation
Fees: € 2.750 + VAT per participant. 3½ days programme.
Click here for a downloadable programme.
Learning Objectives
Using a real–world, phase IIa early clinical development project example, participants will learn how to:
- Avoid the pitfalls of "market–driven" TPPs
- Develop strategic options for possible market positionings and development strategies
- Set milestones for continuing or abandoning the preferred options
- Get a firm grasp of the competitive dynamics and market situation of each option
- Understand the specific risk profile inherent in each option
- Portfolio managers will gain hands on experience in the effective use of real–life processes, methods and tools for future use
- Participants will learn how to balance the different perspectives of project teams, decision makers and portfolio managers
Modules
The selected modules for this course are:
- Option Space Mapping
- Competitive Product Profiles
- Risk Assessment
- Innovativeness Screening
- Decision Tree Analysis
- Project Synthesis
- Portfolio Prioritisation
Fees: € 3.250 + VAT per participant. 4 days programme.
Click here for a downloadable programme.
Learning Objectives
Using a real–world, phase III clinical development project example, participants will learn how to:
- Avoid the pitfalls of "market–driven" TPPs
- Develop strategic options for possible risk mitigation strategies
- Build a comprehensive forecasting model
- Understand the specific risk profile inherent in each option
- Perform an in-depth NPV analysis for the project
- Learn how and when to use different value concepts
- Portfolio managers will gain hands on experience in the effective use of real–life processes, methods and tools for future use
- Participants will learn how to balance the different perspectives of project teams, decision makers and portfolio managers
Modules
The selected modules for this course are:
- Competitive Product Profile
- Risk Assessment
- Competitiveness Modeling
- Decision Tree Analysis
- NPV Analysis
- Project Synthesis
- Portfolio Prioritisation
Fees: € 3.250 + VAT per participant. 4 days programme.
Click here for a downloadable programme.
Decision Analysis for R&D Project Teams
This course covers the strategic options and decision analysis at the level of a project. Course modules include option space; mapping, risk assessment; innovativeness screening and project synthesis.
Courses & Fees for R&D Project Teams
Learning Objectives
Using a real–world lead optimisation (LO) project example, participants will learn how to:
- Avoid the pitfalls of "market–driven" TPPs
- Develop strategic options for possible market positioning and development strategies
- Derive inputs into the targeted LO and PC compound profiles
- Set milestones for continuing or abandoning the preferred options
- Get a firm grasp of the competitive dynamics and market situation of each option
- Understand the specific risk profile inherent in each option
Modules
The selected modules for this course are:
Fees: € 2.250 + VAT per participant. 3 days programme.
Click here for a downloadable programme.
Learning Objectives
Using a real–world, phase IIa clinical development project example, participants will learn how to:
- Avoid the pitfalls of "market–driven" TPPs
- Develop strategic options for possible market positioning and development strategies
- Set milestones for continuing or abandoning the preferred options
- Get a firm grasp of the competitive dynamics and market situation of each option
- Understand the specific risk profile inherent in each option
Modules
The selected modules for this course are:
- Option Space Mapping
- Competitive Product Profiles
- Risk Assessment
- Innovativeness Screening
- Decision Tree Analysis
- Project Synthesis
Fees: € 2.750 + VAT per participant. 3½ days programme.
Click here for a downloadable programme.
Learning Objectives
Using a real-world, phase III clinical development project example, participants will learn how to:
- Avoid the pitfalls of "market–driven" TPPs
- Develop strategic options for possible risk mitigation strategies
- Build a comprehensive forecasting model
- Understand the specific risk profile inherent in each option
- Perform an in–depth NPV analysis for the project
- Learn how and when to use different value concepts
Modules
The selected modules for this course are:
- Competitive Product Profile
- Risk Assessment
- Decision Tree Analysis
- Competitiveness Modeling
- NPV Analysis
- Project Synthesis
Fees: € 2.750 + VAT per participant. 3½ days programme.
Click here for a downloadable programme.